Fabbrica Italiana Sintetici (F.I.S.) Selects Kinaxis for Supply Chain Planning
The government is looking to promote domestic pharma companies' tieups with bulk drug makers in Italy to cut dependence on China for pharmaceutical ingredients.
F.I.S. Fabbrica Italiana Sintetici News Full Screen View
Market Place
Share